Browse > Article
http://dx.doi.org/10.4110/in.2011.11.6.406

Comparison of Invariant NKT Cells with Conventional T Cells by Using Gene Set Enrichment Analysis (GSEA)  

Oh, Sae-Jin (Department of Pathology, Laboratory of Immune Regulation in Department of Biomedical Sciences, Seoul National University College of Medicine)
Ahn, Ji-Ye (Department of Pathology, Laboratory of Immune Regulation in Department of Biomedical Sciences, Seoul National University College of Medicine)
Chung, Doo-Hyun (Department of Pathology, Laboratory of Immune Regulation in Department of Biomedical Sciences, Seoul National University College of Medicine)
Publication Information
IMMUNE NETWORK / v.11, no.6, 2011 , pp. 406-411 More about this Journal
Abstract
Background: Invariant Natural killer T (iNKT) cells, a distinct subset of CD1d-restricted T cells with invariant $V{\alpha}{\beta}$ TCR, functionally bridge innate and adaptive immunity. While iNKT cells share features with conventional T cells in some functional aspects, they simultaneously produce large amount of Th1 and Th2 cytokines upon T-cell receptor (TCR) ligation. However, gene expression pattern in two types of cells has not been well characterized. Methods: we performed comparative microarray analyses of gene expression in murine iNKT cells and conventional $CD4^+CD25^-$ ${\gamma}{\delta}TCR^-$ T cells by using Gene Set Enrichment Analysis (GSEA) method. Results: Here, we describe profound differences in gene expression pattern between iNKT cells and conventional $CD4^+CD25^-$ ${\gamma}{\delta}TCR^-$ T cells. Conclusion: Our results provide new insights into the functional competence of iNKT cells and a better understanding of their various roles during immune responses.
Keywords
NKT cells; conventional T cells; Microarray; GSEA;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Hwang SJ, Kim S, Park WS, Chung DH: IL-4-secreting NKT cells prevent hypersensitivity pneumonitis by suppressing IFN-gamma-producing neutrophils. J Immunol 177;5258-5268, 2006.   DOI
2 Kronenberg M: Toward an understanding of NKT cell biology: progress and paradoxes. Annu Rev Immunol 23;877-900, 2005.   DOI   ScienceOn
3 Bendelac A, Savage PB, Teyton L: The biology of NKT cells. Annu Rev Immunol 25;297-336, 2007.   DOI   ScienceOn
4 Keller A, Backes C, Lenhof HP: Computation of significance scores of unweighted Gene Set Enrichment Analyses. BMC Bioinformatics 8;290, 2007.   DOI
5 Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP: Gene set enrichment analysis: a knowledge- based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102;15545-15550, 2005.   DOI   ScienceOn
6 Taniguchi M, Seino K, Nakayama T: The NKT cell system: bridging innate and acquired immunity. Nat Immunol 4;1164-1165, 2003.   DOI   ScienceOn
7 Bendelac A, Lantz O, Quimby ME, Yewdell JW, Bennink JR, Brutkiewicz RR: CD1 recognition by mouse NK1+ T lymphocytes. Science 268;863-865, 1995.   DOI
8 Chen H, Paul WE: Cultured NK1.1+ CD4+ T cells produce large amounts of IL-4 and IFN-gamma upon activation by anti- CD3 or CD1. J Immunol 159;2240-2249, 1997
9 Mendiratta SK, Martin WD, Hong S, Boesteanu A, Joyce S, Van Kaer L: CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity 6;469-477, 1997.   DOI   ScienceOn
10 Godfrey DI, Stankovic S, Baxter AG: Raising the NKT cell family. Nat Immunol 11;197-206, 2010.   DOI   ScienceOn
11 Kim JH, Kim HY, Kim S, Chung JH, Park WS, Chung DH: Natural killer T (NKT) cells attenuate bleomycin-induced pulmonary fibrosis by producing interferon-gamma. Am J Pathol 167;1231-1241, 2005.   DOI   ScienceOn
12 Oh SJ, Chung DH: Invariant NKT cells producing IL-4 or IL-10, but not IFN-gamma, inhibit the Th1 response in experimental autoimmune encephalomyelitis, whereas none of these cells inhibits the Th17 response. J Immunol 186; 6815-6821, 2011.   DOI   ScienceOn
13 Kim HY, Kim HJ, Min HS, Kim S, Park WS, Park SH, Chung DH: NKT cells promote antibody-induced joint inflammation by suppressing transforming growth factor beta1 production. J Exp Med 201;41-47, 2005.   DOI   ScienceOn